If you were to ask the CEOs of Pfizer, Merck, Lilly, etc., they would be more than happy to drop the “user fees” and have Congress fully fund the FDA via other funding mechanisms.
The Biopharmaceutical Industry Provides 75% Of The FDA’s Drug Review Budget. Is This A Problem?
